| Financial Year |
March 31 2023 |
| Monetary Funds |
18,911,622,286.11 |
| Held-for-trading Financial Assets |
43,317,505,126.27 |
| Notes Receivable |
-- |
| Accounts Receivable |
81,883,141.68 |
| Advances to Suppliers |
156,450,507.95 |
| Other Receivables |
195,015,156.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
925,997,107.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
33,694,600,757.41 |
| Other Current Assets |
4,052,526,729.29 |
| Total Current Assets |
101,420,755,094.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
37,937,890,672.44 |
| Long-term Equity Investment |
29,269,835,325.05 |
| Investment Properties |
25,518,589.20 |
| Fixed Assetes |
1,919,048,852.15 |
| Under-construction Projects |
15,477,389.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
216,562,767.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
39,067,726.76 |
| Deferred Income Tax Assets |
617,559,570.70 |
| Other Non-Current Assets |
1,132,747,648.19 |
| Sub-Total of Non-Current Assets |
76,603,419,831.08 |
| Total Assets |
178,024,174,925.78 |
| Short-Term Loans |
9,461,780,649.20 |
| Trading Financial liabilities |
486,949,661.03 |
| Notes Payable |
1,120,752,801.30 |
| Accounts Payable |
8,350,526.01 |
| Accounts Received In Advance |
4,185,018,554.21 |
| Employee Compensation Payable |
561,972,048.70 |
| Taxes Payable |
483,482,670.96 |
| Interest Payable |
-- |
| Dividend Payable |
268,199,690.81 |
| Other payables |
1,790,270,389.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,417,969,545.37 |
| Other Current Liabilities |
13,509,489,583.15 |
| Sub-Total of Current Liabilities |
73,427,383,197.75 |
| Long-term Loans |
39,719,850,253.34 |
| Bonds Payable |
22,544,090,558.76 |
| Long-Term Accounts Payable |
1,222,942,122.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
369,020,760.14 |
| Deferred Income Tax Liabilities |
433,591,644.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,480,120,876.38 |
| Total Liabilities |
137,907,504,074.13 |
| Paid-In Capital(Or Share Stock) |
5,017,132,462.00 |
| Capital Surplus |
12,228,739,593.57 |
| Surplus Reserve |
854,608,291.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,016,295,802.37 |
| Minority Stockholder's Interest |
12,404,204,976.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,712,465,875.08 |
| Owner's Equity（Stockholder's Equity） |
40,116,670,851.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
178,024,174,925.78 |
